Clinical Trial Update: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating doxercalciferol in patients with myelodysplastic syndromes or related leukemias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Diseases
• Myelodysplastic Syndromes

Drugs mentioned

• DOXERCALCIFEROL (Doxercalciferol)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED